GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Doseology Sciences Inc (XCNQ:MOOD) » Definitions » Scaled Net Operating Assets

Doseology Sciences (XCNQ:MOOD) Scaled Net Operating Assets : -0.03 (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Doseology Sciences Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Doseology Sciences's operating assets for the quarter that ended in Sep. 2024 was C$0.05 Mil. Doseology Sciences's operating liabilities for the quarter that ended in Sep. 2024 was C$0.08 Mil. Doseology Sciences's Total Assets for the quarter that ended in Jun. 2024 was C$1.10 Mil. Therefore, Doseology Sciences's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was -0.03.


Doseology Sciences Scaled Net Operating Assets Historical Data

The historical data trend for Doseology Sciences's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Doseology Sciences Scaled Net Operating Assets Chart

Doseology Sciences Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24
Scaled Net Operating Assets
0.63 -0.41 0.31 0.01 -0.03

Doseology Sciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.05 0.05 -0.04 -0.03

Competitive Comparison of Doseology Sciences's Scaled Net Operating Assets

For the Biotechnology subindustry, Doseology Sciences's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Doseology Sciences's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Doseology Sciences's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Doseology Sciences's Scaled Net Operating Assets falls into.



Doseology Sciences Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Doseology Sciences's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Jun. 2024 )
=(Operating Assets (A: Jun. 2024 )-Operating Liabilities (A: Jun. 2024 ))/Total Assets (A: Jun. 2023 )
=(0.042-0.082)/1.399
=-0.03

where

Operating Assets(A: Jun. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1.102 - 1.06
=0.042

Operating Liabilities(A: Jun. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.082 - 0 - 0
=0.082

Doseology Sciences's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(0.051-0.08)/1.102
=-0.03

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1.041 - 0.99
=0.051

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Doseology Sciences Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Doseology Sciences's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Doseology Sciences Business Description

Traded in Other Exchanges
Address
9-3151 Lakeshore Road, Suite 305, Kelowna, BC, CAN, V1W 3S9
Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. Doseology offers cutting-edge therapeutic products and services, with the focus of making a meaningful impact on the mental health pandemic and improving overall health. Geographically earns it revenue from Canada.

Doseology Sciences Headlines

No Headlines